Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
about
Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
description
clinical trial
@en
ensayo clínico
@es
klinisch onderzoek
@nl
name
Apatinib Combined With PD-1 in ...... tatic Nasopharyngeal Carcinoma
@en
Apatinib Combined With PD-1 in ...... tatic Nasopharyngeal Carcinoma
@nl
type
label
Apatinib Combined With PD-1 in ...... tatic Nasopharyngeal Carcinoma
@en
Apatinib Combined With PD-1 in ...... tatic Nasopharyngeal Carcinoma
@nl
prefLabel
Apatinib Combined With PD-1 in ...... tatic Nasopharyngeal Carcinoma
@en
Apatinib Combined With PD-1 in ...... tatic Nasopharyngeal Carcinoma
@nl
P1050
P1476
A Prospective Multicenter Phas ...... tatic Nasopharyngeal Carcinoma
@en
P3098
NCT04350190
P4844
P580
2020-05-01T00:00:00Z
P582
2021-05-30T00:00:00Z